We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRE
976
DELISTED
Duke Realty Corp.
DRE
$7.81M 0.01%
246,943
-9,365
-4% -$289K
ALGN icon
977
Align Technology
ALGN
$12.3B
$7.8M 0.01%
28,511
-120
-0.4% -$36.2K
GPK icon
978
Graphic Packaging
GPK
$3.58B
$7.79M 0.01%
557,063
-165,370
-23% -$2.22M
PGX icon
979
Invesco Preferred ETF
PGX
$3.78B
$7.75M 0.01%
529,996
+353,516
+200% +$5.16M
FWONK icon
980
Liberty Media Series C
FWONK
$25.8B
$7.75M 0.01%
214,304
+14,588
+7% +$529K
KYN icon
981
Kayne Anderson Energy Infrastructure Fund
KYN
$2.4B
$7.74M 0.01%
505,695
+99,209
+24% +$1.55M
REZI icon
982
Resideo Technologies
REZI
$3.95B
$7.72M 0.01%
352,308
+183,578
+109% +$3.88M
BBWI icon
983
Bath & Body Works
BBWI
$4.1B
$7.64M 0.01%
362,251
+63,989
+21% +$1.27M
STT icon
984
State Street
STT
$50.7B
$7.62M 0.01%
135,900
-13,616
-9% -$846K
BSCL
985
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
$7.61M 0.01%
359,047
-13,028
-4% -$275K
ALLY icon
986
Ally Financial
ALLY
$13.3B
$7.6M 0.01%
245,177
+92,717
+61% +$2.74M
LYV icon
987
Live Nation Entertainment
LYV
$42.1B
$7.54M 0.01%
113,737
+6,659
+6% +$428K
VIOG icon
988
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.13B
$7.52M 0.01%
96,096
+5,718
+6% +$442K
CFG icon
989
Citizens Financial Group
CFG
$30.6B
$7.51M 0.01%
212,485
-8,543
-4% -$298K
EVBG
990
DELISTED
Everbridge, Inc. Common Stock
EVBG
$7.51M 0.01%
83,978
+4,195
+5% +$331K
ITRI icon
991
Itron
ITRI
$4.54B
$7.5M 0.01%
119,819
-37,135
-24% -$2.06M
DCI icon
992
Donaldson
DCI
$11.4B
$7.49M 0.01%
147,260
+95
+0.1% +$4.83K
ATR icon
993
AptarGroup
ATR
$8.61B
$7.46M 0.01%
59,989
-7,275
-11% -$830K
CNP icon
994
CenterPoint Energy
CNP
$26.8B
$7.44M 0.01%
259,862
+17,007
+7% +$507K
SPEM icon
995
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
$7.42M 0.01%
207,330
+7,242
+4% +$257K
L icon
996
Loews
L
$23.6B
$7.37M 0.01%
134,858
-7,150
-5% -$367K
INVX
997
Innovex International
INVX
$1.97B
$7.37M 0.01%
153,430
-312
-0.2% -$13.6K
ISD
998
PGIM High Yield Bond Fund
ISD
$419M
$7.36M 0.01%
502,934
-17,057
-3% -$245K
MLM icon
999
Martin Marietta Materials
MLM
$33B
$7.33M 0.01%
31,865
-2,409
-7% -$522K
SLV icon
1000
iShares Silver Trust
SLV
$30.9B
$7.33M 0.01%
511,507
-3,741
-0.7% -$52.2K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.